Attention Deficit Hyperactivity Disorder Across the Lifespan: The Child, Adolescent, and Adult

Lin-Dyken, 1992, Attention deficit hyperactivity disorder, 167 Still, 1902, The Coulstonian lectures on some abnormal physical conditions in children, Lancet, 1008 Adler, 2002, Management of ADHD in adults, J Clin Psychiatry, 63, 29 Clements, 1966 Ounsted, 1955, The hyperkinetic syndrome in epileptic children, Lancet, II, 3030 Dodson, 2005, Pharmacotherapy of adult ADHD, JCLP/In Session, 61, 589, 10.1002/jclp.20122 2000, 85 Wood, 1976, Diagnosis and treatment of minimum brain dysfunction in adults, Arch Gen Psychiatry, 33, 1456, 10.1001/archpsyc.1976.01770120057005 Wilens, 2002, A review of pharmacotherapy of adults with attention-deficit/hyperactivity disorder, J Atten Dis, 5, 189, 10.1177/108705470100500401 Faraone, 2003, The worldwide prevalence of ADHD: is it an American condition?, World Psychiatry, 2, 104 Kessler, 2006, The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication, Am J Psychiatry, 163, 716, 10.1176/appi.ajp.163.4.716 Katragadda, 2007, ADHD in children, adolescents, and adults, Prim Care Clin Office Pract, 34, 111 Biederman, 2005, Attention-deficit/hyperactivity disorder, Lancet, 366, 237, 10.1016/S0140-6736(05)66915-2 Greydanus, 2006, Attention deficit hyperactivity disorder, 107 Pary, 2002, Attention deficit disorder in adults, Ann Clin Psychiatry, 14, 105, 10.3109/10401230209149097 Biederman, 2005, Attention-deficit/hyperactivity disorder: a selective overview, Biol Psychiatry, 57, 1215, 10.1016/j.biopsych.2004.10.020 Greydanus, 2006, Attention deficit/hyperactivity disorder in adolescents, 751 Faraone, 2006, Candidate gene studies of attention-deficit/hyperactivity disorder, J Clin Psychiatry, 67, 13 Wolraich, 1996, 91 2004, 223 MacDonald, 2006, Behavioral assessment, 651 Larsen, 2006, Psychometric testing, 670 2001 2000 National Institute of Health (NIH). Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder. NIH Consensus Statement Online 1998: Nov 16–18;16(2):1–37. Greydanus, 2003, Attention-deficit/hyperactivity disorder in Children and adolescents: interventions for a complex costly clinical conundrum, Pediatr Clin North Am, 50, 1049, 10.1016/S0031-3955(03)00081-6 Whalen, 1991, Therapies for hyperactive children: Comparisons, combinations, and compromises, J Consult Clin Psychol, 59, 126, 10.1037/0022-006X.59.1.126 Pelham, 2000, Behavior modification, Child Adolesc Psychiatr Clin N Am, 9, 671, 10.1016/S1056-4993(18)30112-3 Pelham, 2002, Effects of methyphenidate and expectancy on children with ADHD: behavior, academic performance, and attributions in a summer treatment program and regular classroom settings, J Consult Clin Psychol, 70, 320, 10.1037/0022-006X.70.2.320 2002 1999 Hinshaw, 1992, Academic underachievement, attention deficits, and aggression: comorbidity and implications for intervention, J Consult Clin Psychol, 60, 893, 10.1037/0022-006X.60.6.893 Jensen, 2001, ADHD comorbidity findings from the MTA study: comparing comorbid subgroups, J Am Acad Child Adolesc Psychiatry, 40, 147, 10.1097/00004583-200102000-00009 Wells, 2000, Parenting and family stress treatment outcomes in attention deficit hyperactivity disorder (ADHD): an empirical analysis in the MTA study, J Abnorm Child Psychol, 28, 543, 10.1023/A:1005131131159 Wells, 2000, Psychosocial treatment strategies in the MTA study: rationale, methods, and critical issues in design and implementation, J Abnorm Child Psychol, 28, 483, 10.1023/A:1005174913412 Greydanus, 2002, Psychopharmacology of ADHD in adolescents, Adolesc Med, 13, 599 Greydanus, 2003, Psychopharmacology of ADHD in adolescents: Quo vadis?, Psychiatr Times, 20, 5 Greydanus, 2007, Attention deficit hyperactivity disorder Greenhill, 2006, The science of stimulant abuse, Pediatr Ann, 35, 552, 10.3928/0090-4481-20060801-07 Bradley, 1937, The behavior of children receiving benzedrine, Am J Psychiatry, 94, 577, 10.1176/ajp.94.3.577 Sallee, 1998, Neuropsychopharmacology III: Psychostimulants, 1351 Angold, 2000, Stimulant treatment for children: a community perspective, J Am Acad Child Adolesc Psychiatry, 39, 975, 10.1097/00004583-200008000-00009 Lefever, 1999, The extent of drug therapy for attention-deficit/hyperactivity disorder among children in public schools, Am J Publ Health, 89, 1359, 10.2105/AJPH.89.9.1359 Rowland, 2002, Prevalence of medication treatment for attention-deficit/hyperactivity disorder among elementary school children in Johnston County, North Carolina, Am J Public Health, 92, 221, 10.2105/AJPH.92.2.231 Safer, 1996, Increased methylphenidate usage for attention deficit disorder in the 1990s, Pediatrics, 98, 1084, 10.1542/peds.98.6.1084 Safer, 2000, Stimulant treatment in Maryland public schools, Pediatrics, 106, 533, 10.1542/peds.106.3.533 Cox, 2003, Geographic variation in the prevalence ofstimulant medication among children 5 to 14 years old: results from a commercially insured US sample, Pediatrics, 111, 237, 10.1542/peds.111.2.237 Zito, 2003, Psychotropic practice patterns for youth, Arch Pediatr Adolesc Med, 157, 17, 10.1001/archpedi.157.1.17 Efron, 2003, Prescribing of psychotrophic medications for children by Australian pediatricians and child psychiatrists, Pediatrics, 111, 372, 10.1542/peds.111.2.372 Rappley, 1999, Diagnosis of attention-deficit/hyperactivity disorder an use of psychotropic medication in very young children, Arch Ped Adolesc Med, 153, 1039, 10.1001/archpedi.153.10.1039 Rappley, 2002, Patterns of psychotropic medication use in very young children with attention-deficit/hyperactivity disorder, Dev Behav Pediatr, 23, 23, 10.1097/00004703-200202000-00005 Zito, 2003, Five burning questions, Dev Behav Pediatr, 23, S23, 10.1097/00004703-200202001-00005 Dreyer, 2006, The diagnosis and management of attention-deficit/hyperactivity disorder in preschool children: the state of our knowledge and practice, Curr Probl Pediatr Adolesc Health Care, 36, 3, 10.1016/j.cppeds.2005.10.001 Guevara, 2002, Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder, Pediatrics, 109, 733, 10.1542/peds.109.5.733 2001, Clinical Practice Guideline: Treatment of the school-aged child with attention-deficit/hyperactivity disorder, Pediatrics, 108, 1033, 10.1542/peds.108.4.1033 Clarke, 2000, ADHD in adolescence, J Adolesc Health, l27, 77, 10.1016/S1054-139X(00)00148-8 Ingram, 1999, Outcomes issues in ADHD-adolescent and adult long-term outcomes, Ment Retard Dev Disabil Res Rev, 5, 243, 10.1002/(SICI)1098-2779(1999)5:3<243::AID-MRDD11>3.0.CO;2-D Rushton, 2001, Pediatric stimulant and selective serotonin reuptake inhibitor prescription trends, 1992 to 1998, Arch Ped Adolesc Med, 155, 560, 10.1001/archpedi.155.5.560 Hechtman, 1984, Young adults outcome of hyperactive children who received long-term stimulant treatment, J Am Acad Child Adolesc Psychiatry, 23, 261, 10.1016/S0002-7138(09)60501-X Solanto, 2001, The neuroscience of stimulant drug action in ADHD Gainetdinov, 1999, Role of serotonin in the paradoxical calming effect of psychostimulants in hyperactivity, Science, 283, 397, 10.1126/science.283.5400.397 Zito, 2000, Trends in the prescribing of psychotropic medications to preschoolers, JAMA, 283, 1025, 10.1001/jama.283.8.1025 Ford, 2003, Stimulants, 255 2004, National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment, Pediatrics, 113, 762, 10.1542/peds.113.4.762 Efron, 1997, Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial, Pediatrics, 100, 662, 10.1542/peds.100.4.662 Greenhill, 1999, Stimulant medications, J Am Acad Child Adolesc Psychiatry, 38, 503, 10.1097/00004583-199905000-00011 Mannuzza, 1991, Hyperactive boys almost grow up: replication of psychiatric status, Arch Gen Psychiatry, 48, 77, 10.1001/archpsyc.1991.01810250079012 Satterfield, 1979, Growth of hyperactive children treated with methylphenidate, Arch Gen Psychiatry, 36, 212, 10.1001/archpsyc.1979.01780020102011 Weiss, 2002, Attention deficit hyperactivity disorder, 645 Miller, 1998, Attention-deficit/hyperactivity disorder, Pediatr Rev, 19, 373, 10.1542/pir.19-11-373 Kuperman, 2002, Tic disorders in the adolescent, Adolesc Med, 13, 537 Robertson, 1989, The Gilles de la Tourette’s syndrome: the current status, Br J Psychiatry, 154, 147, 10.1192/bjp.154.2.147 Varley, 2001, Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medication, Compr Psychiatry, 42, 228, 10.1053/comp.2001.23145 Freeman, 1997, Attention deficit hyperactivity disorder in the presence of Tourette syndrome, Neurol Clin, 191, 411, 10.1016/S0733-8619(05)70322-4 Wender, 2001, Managing stimulant medication for attention-deficit/hyperactivity disorder, Pediatr Rev, 22, 183, 10.1542/pir.22-6-183 Greydanus, 2006, Neurologic disorders, 235 Kuperman, 1992, Tic disorders in children and adolescents, 451 Greenhill, 2002, Practice parameter for the use of stimulant medication in the treatment of children, adolescents and adults, J Am Acad Child Adolesc Psychiatry, 41, 26S, 10.1097/00004583-200202001-00003 Jadad, 1999 Castellanos, 1997, Controlled stimulant treatment of ADHD and comorbid Tourette’s syndrome: Effects of stimulant and dose, J Am Acad Child Adolesc Psychiatry, 36, 589, 10.1097/00004583-199705000-00008 Gadow, 1995, School observation of children with attention deficit hyperactivity disorder and comorbid tic disorder: effects of methylphenidate treatment, J Dev Behav Pediatr, 16, 167, 10.1097/00004703-199506000-00004 Gadow, 1995, Efficacy of methylphenidate for attention deficit hyperactivity disorder in children with tic disorder, Arch Gen Psychiatry, 52, 444, 10.1001/archpsyc.1995.03950180030005 Gadow, 1999, Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder, Arch Gen Psychiatry, 56, 330, 10.1001/archpsyc.56.4.330 Law, 1999, Do typical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?, J Am Acad Child Adolesc Psychiatry, 38, 944, 10.1097/00004583-199908000-00009 Jankovic, 2001, Tourette’s syndrome, N Engl J Med, 345, 1184, 10.1056/NEJMra010032 Robertson, 1992, Pharmacologic controversy of CNS stimulants in Gilles de la Tourette’s syndrome, Clin Neuropharmacol, 15, 408, 10.1097/00002826-199210000-00010 McDougle, 1994, Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder, J Clin Psychiatry, 55, 24 Spencer, 1995, A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder, Arch Gen Psychiatry, 52, 434, 10.1001/archpsyc.1995.03950180020004 Chappell, 1995, Guanfacine treatment of comorbid attention-deficit/hyperactivity disorder and Tourette’s syndrome: preliminary clinical experience, J Am Acad Child Adolesc Psychiatry, 34, 1140, 10.1097/00004583-199509000-00010 Singer, 1995, The treatment of attention-deficit hyperactivity disorder in Tourette’s syndrome: a double-blind placebo-controlled study with clonidine and desipramine, Pediatrics, 95, 74, 10.1542/peds.95.1.74 Steingard, 1993, Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders, J Amer Acad Child Adolesc Psychiatry, 32, 350, 10.1097/00004583-199303000-00016 Michelson, 2001, Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study, Pediatrics, 108, 1197, 10.1542/peds.108.5.e83 Spencer, 1999, Attention-deficit/hyperactivity disorder and comorbidity, Pediatr Clin North Am, 46, 915, 10.1016/S0031-3955(05)70163-2 Anderson, 2006, Methylphenidate transdermal system: in attention deficit hyperactivity disorder in children, Drugs, 66, 1117, 10.2165/00003495-200666080-00007 McGough, 2006, A randomized, double-blind, placebo-controlled laboratory classroom assessment of methylphenidate transdermal system in children with ADHD, J Atten Dis, 9, 476, 10.1177/1087054705284089 2006, Transdermal methylphenidate (Daytrana) for ADHD, Mett Lett, 48, 49 López, 2006, ADHD: new pharmacologic treatments on the horizon, J Dev Behav Pediatr, 27, 410, 10.1097/00004703-200610000-00008 Greydanus, 1997, Psychopharmacology, 874 Adesman, 2002, New medications for treatment of children with attention-deficit/hyperactivity disorder, Pediatr Ann, 31, 514, 10.3928/0090-4481-20020801-11 Boughton, 2003, Methylphenidate patch effectively treats ADHD, Pediatr News, 37, 6 Swanson, 1992 2000, Practice Guideline, Pediatrics, 105, 1158 Rapoport, 1978, Dextroamphetamine: cognitive and behavioral effects in normal prepubertal boys, Science, 199, 560, 10.1126/science.341313 Pliszka, 2006, The Texas Children’s medication algorithm project: revision of the algorithm for pharmacotherapy of attention-deficit hyperactivity disorder, J Am Acad Child Adolesc Psychiatry, 45, 642, 10.1097/01.chi.0000215326.51175.eb Davis, 1992, What pediatricians should know about adolescent psychiatry, Adolesc Med, 3, 131 Kemph, 1993, Treatment of aggressive children with clonidine: Results of an open pilot study, J Am Acad Child Adolesc Psychiatry, 32, 577, 10.1097/00004583-199305000-00013 Hart-Santora, 1992, Clondine in attention deficit hyperactivity disorder, Ann Pharmacother, 26, 37 Silver, 1999, Alternative (nonstimulant) medications in the treatment of attention-deficit/hyperactivity disorder in children, Pediatr Clin North Am, 46, 965, 10.1016/S0031-3955(05)70166-8 Connor, 1999, A meta-analysis of clonidine for symptoms of attention-deficit/hyperactivity disorder, J Am Acad Child Adolesc Psychiatry, 38, 1551, 10.1097/00004583-199912000-00017 Prince, 1996, Clonidine for sleep disturbances associated with attention-deficit/hyperactivity disorder; a systematic chart review of 62 cases, J Am Acad Child Adolesc Psychiatry, 35, 599, 10.1097/00004583-199605000-00014 Pliszka, 2001, Comparing the effects of stimulant and non-stimulant agents on catecholamine function: Implications for theories of ADHD, 332 Blackman, 1996, Clonidine and electrocardiograms, Pediatrics, 98, 1223, 10.1542/peds.98.6.1223a Horrigan, 1995, Guanfacine for treatment of attention-deficit hyperactivity disorder in boys, J Child Adolesc Psychopharmacol, 5, 215, 10.1089/cap.1995.5.215 Hunt, 1995, An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder, J Am Acad Child Adolesc Psychiatry, 34, 50, 10.1097/00004583-199501000-00013 Scahill, 2001, Guanfacine for attention deficit hyperactivity disorder, Am J Psychiatry, 158, 1067, 10.1176/appi.ajp.158.7.1067 Staufer, 2005, Attention-devicit/hyperactivity disorder psychopharmacology for college students, Pediatr Clin North Am, 52, 71, 10.1016/j.pcl.2004.10.007 Clark, 2006, Federal perspective: the abuse of prescription stimulants, Pediatr Ann, 35, 595, 10.3928/0090-4481-20060801-13 Arria, 2006, Nonmedical use of prescription stimulants among students, Pediatr Ann, 35, 557, 10.3928/0090-4481-20060801-09 Musser, 1998, Stimulant use and the potential for abuse in Wisconsin as reported by school administrators and longitudinally followed children, J Dev Behav Pediatr, 19, 187, 10.1097/00004703-199806000-00006 McCabe, 2004, The use, misuse and diversion of prescription stimulants among middle and high school students, Subst Use Misuse, 39, 1095, 10.1081/JA-120038031 Poulin, 2001, Medical and nonmedical stimulant use among adolescents: from sanctioned to unsanctioned use, CMAJ, 165, 1039 Greydanus, 2006 Johnston, 2003 McCabe, 2005, Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey, Addiction, 100, 96, 10.1111/j.1360-0443.2005.00944.x Teter, 2005, Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample, J Am Coll Health, 53, 253, 10.3200/JACH.53.6.253-262 Hall, 2005, Illicit use of prescribed stimulant medication among college students, J Am Coll Health, 53, 167, 10.3200/JACH.53.4.167-174 Graff Low, 2002, Illicit use of psychostimulants among college students: a preliminary study, Psychol Health Med, 7, 283, 10.1080/13548500220139386 Upadhyaya, 2005, Attention-deficit/hyperactivity disorder, medication treatment, and substance use patterns among adolescents and young adults, J Child Adolesc Psychopharmacol, 15, 799, 10.1089/cap.2005.15.799 Rimsza, 2005, Substance abuse on the college campus, Pediatr Clin North Am, 52, 307, 10.1016/j.pcl.2004.10.008 Kadison, 2005, Getting an edge: use of stimulants and antidepressants in college, N Engl J Med, 353, 1089, 10.1056/NEJMp058047 Greydanus, 2005, The adolescent and substance abuse: current concepts, Dis Mon, 51, 392, 10.1016/j.disamonth.2005.10.002 Greydanus, 2005, The adolescent and substance abuse: current concepts, Curr Probl Pediatr Adolesc Health Care, 35, 78, 10.1016/j.cppeds.2004.12.007 Wilford, 2006, Prescription stimulant sales on the internet, Pediatr Ann, 35, 575, 10.3928/0090-4481-20060801-11 2002 Conant-Norville, 2005, Attention deficit/hyperactivity disorder and psychopharmacologic treatments in the athlete, Clin Sports Med, 24, 829, 10.1016/j.csm.2005.05.007 Katusic, 2005, Psychostimulant treatment and risk for substance abuse among young adults with a history of attention-deficit/hyperactivity disorder: a population-based, birth cohort study, J Child Adolesc Psychopharmacol, 15, 764, 10.1089/cap.2005.15.764 Wilens, 2003, Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse?, Pediatrics, 111, 179, 10.1542/peds.111.1.179 Fischer, 2003, Childhood stimulant treatment and risk for later substance abuse, J Clin Psychiatry, 64, 19 Faraone, 2003, Does stimulant treatment lead to substance use disorders?, J Clin Psychiatry, 64, 9 Biederman, 2003, Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youth with and without ADHD, J Clin Psychiatry, 64, 3 Barkley, 2003, Does the treatment of attention deficit/hyperactivity disorder with stimulants contribute to drug use/abuse?, Pediatrics, 111, 97, 10.1542/peds.111.1.97 Mannuzza, 2003, Does stimulant treatment place children at risk for adult substance abuse?, J Child Adolesc Psychopharmacol, 13, 273, 10.1089/104454603322572606 McCabe, 2005, Sources of prescription drugs for illicit use, Addict Behav, 30, 1342, 10.1016/j.addbeh.2005.01.012 Williams, 2004, Methylphenidate and dextroamphetamine abuse in substance-abusing adolescents, Am J Addict, 13, 381, 10.1080/10550490490483053 Murray, 1998, Psychophysiological aspects of amphetamine-methamphetamine abuse, J Psychol, 132, 227, 10.1080/00223989809599162 Luna, 2001, Use and abuse of amphetamine-type stimulants in the United States, Pan A J Public Health, 9, 114, 10.1590/S1020-49892001000200012 Barrett, 2005, Characteristics of methylphenidate misuse in a university student sample, Can J Psychiatry, 50, 457, 10.1177/070674370505000805 Kollins, 2001, Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review, Pharmacol Biochem Behav, 68, 611, 10.1016/S0091-3057(01)00464-6 Kapner DA. Infofacts resources: recreational use of Ritalin on college campuses. Available at: http://www.edc.org/hec/pubs/factsheets/ritalin.htm. Accessed September 15, 2005. Croft, 2006, Physician handling of prescription stimulants, Pediatr Ann, 35, 557, 10.3928/0090-4481-20060801-08 Schubiner, 2005, Substance abuse in patients with attention-deficit/hyperactivity disorder: therapeutic implications, CNS Drugs, 19, 643, 10.2165/00023210-200519080-00001 DuPont, 2006, Abuse-resistant drug delivery, Pediatr Ann, 35, 587, 10.3928/0090-4481-20060801-12 Asherson, 2005, Clinical assessment and treatment of attention deficit hyperactivity disorder in adults, Expert Rev Neurother, 5, 525, 10.1586/14737175.5.4.525 Barkley, 2002, Persistence of attention deficit hyperactivity disorder into adulthood as a function of reporting source and definition of disorder, J Abnorm Psychol, 111, 279, 10.1037/0021-843X.111.2.279 Weiss, 2004, A guide to the treatment of adults with ADHD, J Clin Psychiatry, 65, 27 Weiss, 2003, Assessment and management of attention-deficit hyperactivity disorder in adults, CMAJ, 168, 715 Biederman, 2006, Young adult outcome of attention deficit hyperactivity disorder: a controlled 10 year follow-up study, Psychol Med, 36, 167, 10.1017/S0033291705006410 Barkley, 2002, Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder, J Clin Psychiatry, 63, 10 Barkley, 2004, Driving impairment in teens and adults with attention-deficit/hyperactivity disorder, Psychiatr Clin North Am, 27, 23, 10.1016/S0193-953X(03)00091-1 Kates, 2005, Attention deficit disorder in adults: management in primary care, Canad Fam Pract, 51, 53 Spencer, 2005, A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder, Biol Psychiatry, 57, 456, 10.1016/j.biopsych.2004.11.043 Connor, 2002, Psychopharmacology and aggression, J Am Acad Child Adolesc Psychiatry, 41, 253, 10.1097/00004583-200203000-00004 Rapport, 1997, Titrating methylphenidate in children with attention-deficit/hyperactivity disorder: is body mass predictive of clinical response?, J Am Acad Child Adolesc Psychiatry, 36, 523, 10.1097/00004583-199704000-00015 Wender, 2002, Managing stimulant medication for attention-deficit/hyperactivity disorder: an update, Pediatr Rev, 23, 234, 10.1542/pir.23-7-234 Biederman, 2006, A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder, Biol Psychiatry, 59, 829, 10.1016/j.biopsych.2005.09.011 2000, A new long-acting methylphenidate (Concerta), Med Lett, 42, 80 Swanson, 1999, Acute tolerance to methylphenidate in the treatment of attention- deficit/hyperactivity disorder in children, Clin Pharmacol Ther, 66, 295, 10.1016/S0009-9236(99)70038-X 2001, Another long-acting methylphenidate (Metadate CD), Med Lett, 43, 83 2002, Dexmethylphenidate (Focalin) for ADHD, Med Lett, 44, 45 Johnston, 1993, Methods of evaluating methylphenidate in children with attention-deficit hyperactivity disorder: acceptability, satisfaction, and compliance, J Pediatr Psychol, 18, 717, 10.1093/jpepsy/18.6.717 Barkley, 1998 Markowitz, 1999, Drug interactions with stimulant medications, Int Clin Psychopharmacol, 14, 1, 10.1097/00004850-199901000-00001 Varley, 2000, Sudden death of a child treated with imipramine, J Child Adolesc Psychopharmacol, 10, 321, 10.1089/cap.2000.10.321 Gross-Tsur, 1997, Epilepsy and attention deficit hyperactivity disorder: Is methylphenidate safe and effective?, J Pediatr, 130, 670, 10.1016/S0022-3476(97)70258-0 Rappley, 1997, Safety issues in the use of methylphenidate, Drug Saf, 17, 143, 10.2165/00002018-199717030-00001 Nissen, 2006, ADHD and cardiovascular risk, N Engl J Med, 354, 1445, 10.1056/NEJMp068049 Wilens, 2006, Stimulants and sudden death: what is a physician to do?, Pediatrics, 118, 1215, 10.1542/peds.2006-0942 Anders, 2006, ADHD drugs and cardiovascular risk, N Engl J Med, 354, 2296, 10.1056/NEJMc061187 Spencer, 2005, A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder, Biol Psychiatry, 57, 456, 10.1016/j.biopsych.2004.11.043 2002, Generic Drugs, Med Lett, 44, 89 1994, Adderall and other drugs for attention-deficit/hyperactivity disorder, Med Lett Dr Ther, 36, 109 Weisler, 2006, Mixed amphetamine salts extended release inthe treatment of adult ADHD: a randomized, controlled trial, CNS Spectr, 11, 625, 10.1017/S1092852900013687 Biederman, 2005, Long-term safety and effectiveness of mixed amphetamine salts with extended release in adults with ADHD, CNS Spectr, 10, 16, 10.1017/S1092852900002406 Wilens, 2001, Bupropion for attention-deficit/hyperactivity disorder, Am J Psychiatry, 158, 282, 10.1176/appi.ajp.158.2.282 Patel, 2000, Office interventions for adolescent smokers, Adolesc Med, 11, 577 Spencer, 1993, Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette’s syndrome, J Am Acad Child Adolesc Psychiatry, 32, 211, 10.1097/00004583-199301000-00030 Adler, 2005, Long-term, open-label study of the safety and efficacy of atomoxetine in adults with attention-deficit/hyperactivity disorder: an interim analysis, J Clin Psychiatry, 66, 294, 10.4088/JCP.v66n0304 Michelson, 2003, Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies, Biol Psychiatry, 53, 112, 10.1016/S0006-3223(02)01671-2 2003, Atomoxetine (Strattera) for ADHD, Med Lett, 45, 11 Kratochvil, 2002, Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial, J Am Acad Child Adolesc Psychiatr, 41, 776, 10.1097/00004583-200207000-00008 Allen, 2001, Safety and efficacy of atomoxetine for AHDH in two double-blind, placebo-controlled trials, Biol Psychiatry, 49, 32S Wilens, 2006, Long-term atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder, J Pediatr, 149, 112, 10.1016/j.jpeds.2006.01.052 Michelson, 2002, Once-daily atomoxetine treatment for children and adolescents with ADHD: a randomized, placebo-controlled study, Am J Psychiatry, 159, 1896, 10.1176/appi.ajp.159.11.1896 Geller, 1999, Critical review of tricyclic antidepressant use in children and adolescents, J Am Acad Child Adolesc Psychiatry, 38, 513, 10.1097/00004583-199905000-00012 Prince, 2000, Nortriptyline in pediatric ADHD, J Child Adolesc Psychopharmacol, 10, 193, 10.1089/10445460050167304 Wilens, 1995, A systematic assessment of tricyclic antidepressants in the treatment of adult attention-deficit hyperactivity disorder, J Nervous Mental Dis, 48, 183 Brent, 2002, Adolescent depression, N Engl J Med, 347, 667, 10.1056/NEJMcp012249 Harvey, 1995, Interactions of serotonin reuptake inhibitors with tricyclic antidepressants, Arch Gen Psychiatry, 52, 783, 10.1001/archpsyc.1995.03950210077014 Bartels, 1991, Pediatric cardiovascular effects of imipramine and desipramine, J Am Acad Child Adolesc Psychiatry, 30, 100, 10.1097/00004583-199101000-00015 Varley, 2003, Anxiety disorders in children and adolescents, Pediatr Clin North Am, 50, 530, 10.1016/S0031-3955(03)00070-1 Varley, 2001, Sudden death related to selected tricyclic antidepressants in children: epidemiology, mechanisms and clinical implications, Paediatr Drugs, 3, 613, 10.2165/00128072-200103080-00006 1990, Sudden death in children treated with a tricyclic antidepressant, Med Lett, 32, 53 Varley, 1997, Case study: two additional sudden deaths with tricyclic antidepressants, J Am Acad Child Adolesc Psychiatry, 36, 390, 10.1097/00004583-199703000-00018 Findling, 1996, Venlafaxine in adults with attention- deficit/hyperactivity disorder: an open clinical trial, J Clin Psychiatr, 57, 184 Adler, 2002, Management of ADHD in adults, J Clin Psychiatr, 63, 29 Chan, 2003, Complementary and alternative therapies in childhood attention and hyperactivity problems, J Dev Behav Pediatr, 24, 4, 10.1097/00004703-200302000-00003 Baumgaertel, 1999, Alternative and controversial treatments for attention-deficit/hyperactivity disorder, Pediatr Clin North Am, 46, 977, 10.1016/S0031-3955(05)70167-X Konofal, 2005, Ropinirole in a child with attention-deficit hyperactivity disorder and restless legs syndrome, Pediatr Neurol, 32, 350, 10.1016/j.pediatrneurol.2004.11.007 Barkley, 1998, Attention-deficit/hyperactivity disorder, Sci Am, 279, 66, 10.1038/scientificamerican0998-66 Okie, 2006, ADHD in adults, N Engl J Med, 354, 2637, 10.1056/NEJMp068113